Paradigm Biocapital Advisors as of June 30, 2023
Portfolio Holdings for Paradigm Biocapital Advisors
Paradigm Biocapital Advisors holds 29 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Legend Biotech Corp Sponsored Ads (LEGN) | 9.6 | $125M | 1.8M | 69.03 | |
| Argenx Se Sponsored Adr (ARGX) | 8.8 | $114M | 292k | 389.73 | |
| Incyte Corporation (INCY) | 6.6 | $86M | 1.4M | 62.25 | |
| Immunocore Hldgs Ads (IMCR) | 5.9 | $76M | 1.3M | 59.96 | |
| Arcellx Common Stock (ACLX) | 5.7 | $74M | 2.3M | 31.62 | |
| Karuna Therapeutics Ord | 4.8 | $62M | 284k | 216.85 | |
| Cerevel Therapeutics Hldng I (CERE) | 4.6 | $59M | 1.9M | 31.79 | |
| Miragen Therapeutics (VRDN) | 4.4 | $58M | 2.4M | 23.79 | |
| United Therapeutics Corporation (UTHR) | 4.1 | $53M | 238k | 220.75 | |
| Mirati Therapeutics | 4.0 | $52M | 1.4M | 36.13 | |
| Syndax Pharmaceuticals (SNDX) | 3.9 | $51M | 2.4M | 20.93 | |
| Bicycle Therapeutics Sponsored Ads (BCYC) | 3.9 | $51M | 2.0M | 25.52 | |
| Nuvalent Inc-a (NUVL) | 3.7 | $47M | 1.1M | 42.17 | |
| Beigene Sponsored Adr (BGNE) | 3.0 | $39M | 216k | 178.30 | |
| Xenon Pharmaceuticals (XENE) | 2.9 | $38M | 989k | 38.50 | |
| Olema Pharmaceuticals (OLMA) | 2.6 | $34M | 3.7M | 9.03 | |
| Ambrx Biopharma Sponsored Ads | 2.1 | $27M | 1.7M | 16.46 | |
| Crinetics Pharmaceuticals In (CRNX) | 1.9 | $25M | 1.4M | 18.02 | |
| Alpine Immune Sciences (ALPN) | 1.9 | $25M | 2.4M | 10.28 | |
| Vir Biotechnology (VIR) | 1.9 | $25M | 1.0M | 24.53 | |
| Zai Lab Adr (ZLAB) | 1.9 | $24M | 865k | 27.73 | |
| Immatics SHS (IMTX) | 1.8 | $23M | 2.0M | 11.54 | |
| Autolus Therapeutics Spon Ads (AUTL) | 1.7 | $22M | 9.2M | 2.38 | |
| Vor Biopharma (VOR) | 1.5 | $20M | 6.5M | 3.09 | |
| Madrigal Pharmaceuticals (MDGL) | 1.5 | $20M | 85k | 231.00 | |
| Verona Pharma Sponsored Ads (VRNA) | 1.5 | $19M | 894k | 21.14 | |
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 1.5 | $19M | 370k | 51.00 | |
| Theseus Pharmaceuticals | 1.4 | $18M | 2.0M | 9.33 | |
| Kura Oncology (KURA) | 0.8 | $11M | 1.0M | 10.58 |
